📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression. (2013)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1164/rccm.201206-1028oc

PubMed Identifier: 23087024

Publication URI: http://europepmc.org/abstract/MED/23087024

Type: Journal Article/Review

Volume: 187

Parent Publication: American journal of respiratory and critical care medicine

Issue: 1

ISSN: 1073-449X